MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR

Jian-Hua Duan1, Long Fang

  • 1Department of Gastroenterology, Second Hospital of Shaoxing City, Shaoxing, Zhejiang Province, 312000, China, jianhuaduan@126.com.

Insights

MicroRNAs (miRNAs) like miR-92 are upregulated in gastric cancer, promoting tumor growth and invasion. Targeting miR-92 could be a new strategy for treating this disease.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs crucial in regulating gene expression.
  • Dysregulation of miRNAs is implicated in various human cancers, including gastric cancer.
  • Understanding specific miRNA roles, like miR-92, is vital for cancer research.

Purpose of the Study:

  • To investigate the role of miR-92 in gastric cancer development.
  • To determine the association between miR-92 expression and clinical characteristics.
  • To identify direct targets of miR-92 in gastric cancer cells.

Main Methods:

  • Quantitative analysis of miR-92 expression in gastric cancer tissues versus normal tissues.
  • In vitro gain-of-function and loss-of-function experiments to assess miR-92's impact on cell proliferation and invasion.
  • Luciferase reporter assays and Western blot to validate direct targeting of Farnesoid X Receptor (FXR) by miR-92.

Main Results:

  • miR-92 was significantly upregulated in gastric cancer tissues.
  • miR-92 expression levels correlated with specific clinical characteristics of patients.
  • Overexpression of miR-92 enhanced gastric cancer cell proliferation and invasion.
  • Inhibition of miR-92 suppressed these cellular behaviors.
  • FXR was identified as a direct target gene of miR-92.

Conclusions:

  • Upregulation of miR-92 is a potential mechanism driving gastric cancer progression.
  • miR-92 promotes gastric cancer cell proliferation and invasion, partly through targeting FXR.
  • miR-92 may serve as a diagnostic biomarker or therapeutic target for gastric cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K